semaglutide class action lawsuit A class-action has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly's blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager informed patients Class Action Vs. Individual Ozempic

Prodigiosin-loaded electrospun nanofibers scaffold for localized treatment of triple negative breast cancer

We all knew that weight was not good for us, but we didnt understand until now that it was causal in these chronic diseases, certain forms of cancer, potentially some of the neurodegenerative diseases

At the same time, healthcare systems are facing increasing pressure to control spending

FDA's concerns with unapproved GLP-1 drugs used for weight loss

Studies show that patients who use GLP medications alongside intensive lifestyle modifications have more significant weight loss compared to people who used medications alone, says Dr